Matches in Wikidata for { <http://www.wikidata.org/entity/Q66033551> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q66033551 description "clinical trial" @default.
- Q66033551 description "ensayu clínicu" @default.
- Q66033551 description "klinisch onderzoek" @default.
- Q66033551 description "клінічне випробування" @default.
- Q66033551 name "Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine." @default.
- Q66033551 name "Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine." @default.
- Q66033551 type Item @default.
- Q66033551 label "Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine." @default.
- Q66033551 label "Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine." @default.
- Q66033551 prefLabel "Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine." @default.
- Q66033551 prefLabel "Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine." @default.
- Q66033551 P1132 Q66033551-959CD37B-3249-4D58-8A38-86BAAB44A198 @default.
- Q66033551 P1476 Q66033551-80C226BF-C181-45F8-8491-E426BB66DA1F @default.
- Q66033551 P17 Q66033551-00BB4D36-4D39-476E-A2D7-91F4A5E235CB @default.
- Q66033551 P17 Q66033551-494C0002-5792-4570-914E-2087EF5B8E21 @default.
- Q66033551 P17 Q66033551-5EE182FF-0490-4A31-A963-9B5612008D80 @default.
- Q66033551 P17 Q66033551-5F17898E-9D15-4BE9-BC3D-9B00EA068E03 @default.
- Q66033551 P2899 Q66033551-24B398E9-39FD-4B51-B157-E2C04E490D56 @default.
- Q66033551 P3098 Q66033551-DBFE620F-1D68-483C-8241-08C746D37359 @default.
- Q66033551 P31 Q66033551-A22C63EB-775B-4A87-A362-E717FB38FD24 @default.
- Q66033551 P4844 Q66033551-08754AE2-B5C9-4A12-AE95-9142614668EB @default.
- Q66033551 P4844 Q66033551-AF393764-BE8F-4BC1-AC6D-6B3C7C21FCB8 @default.
- Q66033551 P4844 Q66033551-B65DD83C-FAAA-4291-8F6A-D64AB70BB101 @default.
- Q66033551 P580 Q66033551-2F43128A-FCBF-479D-977C-B503FEFFF6C2 @default.
- Q66033551 P582 Q66033551-880FF648-3D70-4A12-BC42-AFB2441BA550 @default.
- Q66033551 P6099 Q66033551-0350ACA6-0FA8-47AF-A443-39F438B03AAC @default.
- Q66033551 P6153 Q66033551-3384E8E3-50E6-4402-9005-385CE991AB1A @default.
- Q66033551 P8363 Q66033551-0CA4E274-A6E3-4159-A30D-AD754F2D98A0 @default.
- Q66033551 P1132 "+547" @default.
- Q66033551 P1476 "A Randomized, Multi-Center Phase III Trial Of Irinotecan In Combination With Three Different Methods Of Administration Of Fluoropyrimidine: Infusional 5-FU (FOLFIRI), Modified-Bolus 5-FU (Day 1 & 8), And Oral Capecitabine (Day 1-14); With Celecoxib Versus Placebo As First-Line Treatment For Patients With Metastatic Colorectal Cancer Study Amended April 23, 2004 To Include Bevacizumab" @default.
- Q66033551 P17 Q16 @default.
- Q66033551 P17 Q30 @default.
- Q66033551 P17 Q408 @default.
- Q66033551 P17 Q664 @default.
- Q66033551 P2899 "+18" @default.
- Q66033551 P3098 "NCT00101686" @default.
- Q66033551 P31 Q30612 @default.
- Q66033551 P4844 Q238512 @default.
- Q66033551 P4844 Q412197 @default.
- Q66033551 P4844 Q413299 @default.
- Q66033551 P580 "2003-02-01T00:00:00Z" @default.
- Q66033551 P582 "2008-10-01T00:00:00Z" @default.
- Q66033551 P6099 Q42824827 @default.
- Q66033551 P6153 Q206921 @default.
- Q66033551 P8363 Q78089383 @default.